On Tuesday, Citi Research analysts initiated coverage on shares Nu Skin Enterprises, Inc. NUS with a Neutral rating and $46 price target.
Beth Kite stated, “despite the much-lowered EPS expectations for 2015, until we see less risk to EPS and/or a stronger probability for upside—from either a rebound in China or more visibility into 2015 innovation plans—we think it’s still too early to call an inflection in the stock.”
"Upcoming catalysts: Dec. 4 Citi visits Nu Skin in Shanghai; Dec. 12 the company hosts its Investor Day, analysts expect to hear a long-term strategy for China, innovation roll-out plans and the potential for re-entry into Brazil."
Shares of Nu Skin Enterprises were trading up 1 percent Tuesday morning.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.